Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
![]() |
AmgenAMGN |
15,010 0% |
![]() |
Gilead SciencesGILD |
77,597 0% |
![]() |
Catalyst PharmaceuticalsCPRX |
15,491 0% |
![]() |
Inovio PharmaceuticalsINO |
92,264 0% |
![]() |
Anavex Life SciencesAVXL |
23,920 0% |
Inhibrx Biosciences Stocktwits Subscriber Count
Inhibrx Biosciences (INBX) has 821 subscribers on Stocktwits, up 8.6% over the past three months. A growing subscriber base points to rising retail investor interest in the stock.
With 821 subscribers, Inhibrx Biosciences has a smaller Stocktwits following than Amgen (15,010) and Gilead Sciences (77,597).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How INBX’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking INBX. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Inhibrx Biosciences’s Stocktwits community into the INBX AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see INBX Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Sep 2026 | 801 | |
| Aug 2026 | 767 | |
| Jul 2026 | 756 |
Inhibrx Biosciences Stocktwits Subscribers: Frequently Asked Questions
Inhibrx Biosciences (INBX) has 821 subscribers (821) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Inhibrx Biosciences's Stocktwits subscriber base is growing, up 8.6% over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines INBX’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Inhibrx Biosciences underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 1st percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Inhibrx Biosciences.
See Inhibrx Biosciences’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for INBX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE




